| Secondary |
| Product Used For Unknown Indication |
39.0% |
| Rash |
8.2% |
| Adult T-cell Lymphoma/leukaemia |
6.8% |
| Hiv Infection |
6.8% |
| Osteoarthritis |
5.5% |
| Hypertension |
4.1% |
| Type 2 Diabetes Mellitus |
4.1% |
| Cardiovascular Disorder |
2.7% |
| Oedema Peripheral |
2.7% |
| Pollakiuria |
2.7% |
| Rhinitis Allergic |
2.7% |
| Tinea Infection |
2.7% |
| Herpes Zoster |
2.1% |
| Analgesia |
1.4% |
| Back Pain |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Cardiotoxicity |
1.4% |
| Carotid Arteriosclerosis |
1.4% |
| Cataract |
1.4% |
| Depression |
1.4% |
|
| Drug Ineffective |
14.3% |
| Myocardial Ischaemia |
14.3% |
| Tinnitus |
14.3% |
| Tremor |
14.3% |
| Liver Disorder |
7.1% |
| Muscle Spasms |
7.1% |
| Myalgia |
7.1% |
| Rhabdomyolysis |
7.1% |
| Second Primary Malignancy |
7.1% |
| Vitamin B6 Deficiency |
7.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
36.4% |
| Product Used For Unknown Indication |
19.4% |
| Hypertension |
5.1% |
| Blood Cholesterol Increased |
3.9% |
| Prophylaxis |
3.7% |
| Osteoporosis |
3.3% |
| Pain |
2.9% |
| Routine Health Maintenance |
2.8% |
| Rheumatoid Arthritis |
2.5% |
| Hyperlipidaemia |
2.3% |
| Diabetes Mellitus |
2.2% |
| Vitamin Supplementation |
2.0% |
| Back Pain |
2.0% |
| Constipation |
2.0% |
| Hypersensitivity |
1.9% |
| Osteopenia |
1.9% |
| Blood Cholesterol |
1.8% |
| Cardiac Disorder |
1.5% |
| Depression |
1.4% |
| Hypothyroidism |
1.2% |
|
| Vomiting |
12.7% |
| Flushing |
9.2% |
| Headache |
7.0% |
| Nausea |
7.0% |
| Drug Ineffective |
6.3% |
| Amyotrophic Lateral Sclerosis |
5.6% |
| Dizziness |
4.9% |
| Myalgia |
4.2% |
| Pruritus |
4.2% |
| Weight Increased |
4.2% |
| Muscle Spasms |
3.5% |
| Myocardial Infarction |
3.5% |
| Pain |
3.5% |
| Pain In Extremity |
3.5% |
| Rhabdomyolysis |
3.5% |
| Somnolence |
3.5% |
| Thrombocytopenia |
3.5% |
| Weight Decreased |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Hypersensitivity |
2.8% |
|
| Interacting |
| Drug Use For Unknown Indication |
40.0% |
| Depression |
10.0% |
| Dyskinesia |
10.0% |
| Gait Disturbance |
10.0% |
| Initial Insomnia |
10.0% |
| Motor Dysfunction |
10.0% |
| Muscle Rigidity |
10.0% |
|
|
